Peter R. Lenahan
FDA investigator
Appears on 1 document from 2018, mostly at sites in New Jersey. Most often cites 21 CFR 11.
- 1
- Documents on file
- 4.0
- Observations per 483
- 2018
- First seen
- 2018
- Most recent
What they cite most
From 4 observations- 21 CFR 111
- 21 CFR 312.50General responsibilities of sponsors1
- 21 CFR 312.55(b)Informing investigators1
- 21 CFR 312.6(a)Labeling of an investigational new drug1
Activity by year
2018: 1
Where
New Jersey 1
Is Peter R. Lenahan coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2018-08-01 | 483 Immunomedics, Inc.Aug 1, 2018 · Morr is Plains, New Jersey | Morr is Plains, New Jersey | 4 |
About this profile
What does Peter R. Lenahan inspect?
Peter R. Lenahan appears on 1 document on file covering 1 site, mostly in New Jersey.
What do they cite most often?
21 CFR 11, followed by 21 CFR 312.50 and 21 CFR 312.55(b).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Peter R. Lenahan is dated Aug 1, 2018.